RGNT
Regentis Biomaterials Ltd.Company with tickers: RGNT
CIK
1912966
CUSIP
M8211G108
Shares Outstanding
5,179,378
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-6,968,000 | USD | 2025-12-31 | Other | 2026-02-27 |
| Net Income | $-13,648,000 | USD | 2025-12-31 | Other | 2026-02-27 |
| EPS (Basic) | $-24.16 | USD/shares | 2025-12-31 | Other | 2026-02-27 |
| EPS (Diluted) | $-24.16 | USD/shares | 2025-12-31 | Other | 2026-02-27 |